Back to results
US 2004/0018153 A1Published application
HFA suspension formulations containing an anticholinergic
AssigneeBoehringer Ingelheim Pharma GmbH & Co. KG
InventorChristel Schmelzer
Life of this patent
Estimating the term…
Abstract
The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate of (1α,2β,4β,5α,7β)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane-bromide.
Claims10
1) A suspension of crystalline tiotropium bromide monohydrate in propellant gases HFA 227 and/or HFA 134a, optionally in admixture with one or more other propellant gases chosen from propane, butane, pentane, dimethylether, CHClF2, CH2F2, CF3CH3, isobutane, isopentane and neopentane.
Dependencies are inferred from the claim text.